ストックスクリーナーアプリを入手
14.64
0.07%
0.010
アフターアワーズ：
14.64
前日終値:
$14.63
開ける：
$14.82
24時間の取引高:
673.52K
Relative Volume:
0.45
時価総額：
$1.28B
収益：
-
当期純損益:
$-162.45M
株価収益率:
-7.8515
EPS:
-1.8646
ネットキャッシュフロー:
$-146.72M
1週間 パフォーマンス:
+0.34%
1か月 パフォーマンス:
-2.79%
6か月 パフォーマンス:
+84.15%
1年 パフォーマンス:
+163.31%
1日の値動き範囲:
$14.29
$15.12
1週間の範囲:
$13.98
$15.12
52週間の値動き範囲:
$3.89
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
14.64 | 1.28B | 0 | -162.45M | -146.72M | -1.8646 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | Wolfe Research | Peer Perform |
| 2026-03-19 | 再開されました | Jefferies | Buy |
| 2026-02-11 | 開始されました | Stifel | Buy |
| 2026-01-07 | 開始されました | Piper Sandler | Overweight |
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-12 | 繰り返されました | Citigroup | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Olema Pharmaceuticals (OLMA) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Olema Pharmaceuticals seeks senior director to drive breast cancer marketing strategy - Traders Union
Five new Olema hires receive stock options at $14.32 a share - Stock Titan
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Olema Adds Deal Veteran Prakash Raman To Guide Oncology Partnerships - Sahm
Olema Pharmaceuticals, Inc. Announces New Lease Agreement and Provides Company Information – Form 8-K Filing - Minichart
Jennison Associates LLC Takes Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Pictet Asset Management Holding SA Trims Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point - TipRanks
Olema Pharmaceuticals (NASDAQ: OLMA) inks 7-year HQ lease with $18.5M base rent - Stock Titan
OLMA Forecast, Price Target & Analyst Ratings | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash - Moomoo
Olema (NASDAQ: OLMA) director granted 27,061 stock options - Stock Titan
Olema Pharmaceuticals Adds Veteran Director to Support Growth - TipRanks
Olema Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- Raman Prakash - Moomoo
New Olema (OLMA) director files initial insider ownership report - Stock Titan
[ARS] Olema Pharmaceuticals, Inc. SEC Filing - Stock Titan
Executive pay and board seats on ballot at Olema (NASDAQ: OLMA) 2026 meeting - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event - Stock Titan
Olema Pharmaceuticals appoints Prakash Raman to board By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals appoints Prakash Raman to board - Investing.com
Prakash Raman named to Olema Pharmaceuticals board - Traders Union
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors - Caledonian Record
Olema Pharmaceuticals (OLMA) loses 33.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Wall Street Zen Upgrades Olema Pharmaceuticals (NASDAQ:OLMA) to "Sell" - MarketBeat
Olema Pharmaceuticals seeks lead senior medical writer to strengthen oncology portfolio - Traders Union
OLMA (Olema Pharmaceuticals Inc.) posts narrow Q4 2025 EPS beat, sending shares up two percent in daily trading.Consensus Forecast - Cổng thông tin điện tử tỉnh Tây Ninh
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Olema Pharmaceuticals (OLMA) to Showcase Phase 1 Study Results a - GuruFocus
Olema brings first human OP-3136 cancer trial results to ASCO - Stock Titan
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting - marketscreener.com
Jim Cramer on Olema Pharmaceuticals: "Too risky for me" - MSN
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - MSN
Olema Pharmaceuticals expands workforce to drive oncology innovation - Traders Union
Can Olema Pharmaceuticals (OLMA) stock keep rising today (Slight Gain) 2026-04-20Community Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Olema Pharmaceuticals (OLMA) Is Up 5.6% After Preclinical Data Highlight Deeper ER Blockade Potential - Sahm
A Look At Olema Pharmaceuticals (OLMA) Valuation After New Preclinical Breast Cancer Data - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting - Sahm
Olema Pharmaceuticals (OLMA) Stock: Why It Could Break Down (Smart Money Flows) 2026-04-18 - Cổng thông tin điện tử tỉnh Lào Cai
Olema Pharmaceuticals (OLMA) Unveils New Data on Palazestrant - GuruFocus
Olema Pharmaceuticals unveils new preclinical data ahead of AACR2026 presentation - Traders Union
Olema Pharmaceuticals, Inc. (OLMA) Stock Report: Exploring a Potential 160% Upside in the Biotech Sector - DirectorsTalk Interviews
Early development of Olema and Aurigene’s OP-3136 for breast cancer - BioWorld News
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Rate Cut: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2026 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):